Epigenetics in cancer: a promising path to follow?
- PMID: 30973822
- DOI: 10.1515/cclm-2019-0010
Epigenetics in cancer: a promising path to follow?
References
-
- Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983;111:47–54.
-
- Kuhlmann JD, Chebouti I, Kimmig R, Buderath P, Reuter M, Puppel SH, et al. Extracellular vesicle-associated miRNAs in ovarian cancer – design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance. Clin Chem Lab Med 2019;57:1053–62.
-
- Terrinoni A, Calabrese C, Basso D, Aita A, Caporali S, Plebani M, et al. The circulating miRNAs as diagnostic and prognostic markers. Clin Chem Lab Med 2019;57:932–53.
-
- Zong W, Feng W, Jiang Y, Ju S, Jing R, Cui M. Evaluating the diagnostic and prognostic value of serum long noncoding RNA CTC-497E21.4 in gastric cancer 2019;57:1063–72.
-
- Liu H, Ye D, Chen A, Tan D, Zhang W, Jiang W. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers. Clin Chem Lab Med 2019;57:1073–83.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources